The new Syrina 2.25 is a compact auto-injector that uses the standard 2.25 mL prefilled syringe, based on Bespak’s proprietary VapourSoft technology.
Drug-delivery company, Bespak, is launching its new auto-injector, Syrina 2.25 at PDA Europe 2015. Steven Kaufman, Bespak’s global business development lead, will chair a one-day specialized industry discussion on innovative combinational products at a workshop taking place during the PDA Europe 2015 Universe of Pre-filled Syringes & Injection Devices in Vienna, Austria.
Key focus areas to be addressed at the workshop include advanced technologies in the field of self-injection devices, ranging from auto, pen, bolus, and wearable-injectors through to pumps. The event will focus on how innovation in the design of combination products will help overcome industry challenges, improve compliance, and enhance the patient experience.
The discussion will focus on how primary containers, such as prefilled syringes and cartridges, both in plastic and in glass form, can be effectively integrated into such devices. The workshop will also look the challenges and approaches for successfully taking combinational products to market.
Bespak has chosen this event to launch the latest addition to the Syrina product range, Syrina 2.25. This new product will highlight the technology’s flexibility, which addresses the need for higher volume and highly viscous solutions.
The Syrina range of self-injection devices, which span assisted syringes with needle safety features through to fully functioning auto-injectors, all use Bespak’s proven VapourSoft powerpack system.
Source: Bespak
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.